HTGF has returned to back Freiburg's single cell-dispensing spinout Cytena after previously featuring in the company’s $1.3m round in 2015.

Cytena, a Germany-based single-cell printing technology spinout from University of Freiburg, has closed a €3m ($3.4m) series A round featuring public-private partnership High-Tech Gründerfonds (HTGF) and two unnamed angel investors. Founded in 2014, Cytena markets a range of lab machines that dispense and sort live biological cells to be used in biopharmaceutical drug development as…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.